Plasmid Purification Market Size To Reach $3.69 Billion By 2030

The global plasmid purification market size is anticipated to reach USD 3.69 billion by 2030 and is projected to grow at a CAGR of 11.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising acceptance of cell & gene therapy and growing demand for recombinant technology products are factors contributing to market growth. Moreover, technological advancements in plasmid purification further propel market growth.

Plasmids are crucial in gene therapy and genetic medicine. Their unique properties allow them to serve as effective vectors for delivering therapeutic genes into target cells. Plasmids function by introducing exogenous genes into specific cells to correct or replace defective genes responsible for diseases. Moreover, with the increasing acceptance and application of gene therapy for treating various diseases, there is a growing need for purified plasmid DNA. In gene therapy, plasmids serve as vectors for delivering therapeutic genes.

Researchers design plasmids to carry therapeutic genes, including normal copies of mutated genes, genes encoding proteins to combat disease, or RNA molecules like shRNA that can silence harmful genes. Plasmid purification is critical in the development and application of gene therapy. Contaminants such as chromosomal DNA, proteins, endotoxins, and residual bacterial components can interfere with the efficacy and safety of the therapeutic product. Thus, advancements in purification technologies enhance the yield and quality of plasmid DNA, facilitating the scalability of plasmid production, which is essential for meeting the increasing demands of gene therapy development.

The COVID-19 pandemic has significantly impacted the market growth. The increased demand for synthetic biology products, driven by the urgent need for COVID-19 vaccines and treatments, has accelerated research and development (R&D) in cloning technology. This surge in R&D activities in synthetic biology has led to increased funding and investment in companies involved in vaccine development, diagnostics, and therapeutic research. Moreover, despite the challenges posed by the pandemic, the market is expected to continue growing steadily due to the increasing adoption of novel technologies, the rising demand for gene therapies, and ongoing advancements in genetic engineering.

However, one of the primary concerns of the market is the ethical constraints related to the use of recombinant DNA technology is the misuse of gene cloning and synthesis technology in the creation of harmful pathogens through synthetic biology techniques to develop bioweapons. Improper handling or disposal of synthetic DNA and plasmids could lead to environmental contamination. Engineered organisms released into the environment could have ecological consequences.

List of Key Players in the Plasmid Purification Market

• Merck KGaA
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Takara Bio
• Promega Corporation
• Zymo Research
• MP BIOMEDICALS
• New England Biolabs
• MCLAB
• Applied Biological Materials Inc.

Request a free sample copy or view report summary: Plasmid Purification Market Report

Plasmid Purification Market Report Highlights

• The products segment led the market with the largest revenue share of 72.93% in 2023, as the use of specialized kits and reagents significantly enhances the efficiency, reliability, and quality of the purification process. Furthermore, the services segment is anticipated to experience at a significant CAGR of 12.58% from 2024 to 2030
• Based on grade, the molecular grade segment led the market with the largest revenue share of 58.42% in 2023, as these plasmids are engineered to be easily manipulated and modified, allowing researchers to make precise changes to the genetic material. The transfection grade segment is anticipated to grow at the fastest CAGR of 13.24% over the forecast period
• Based on application, the cloning & protein segment led the market with the largest revenue share of 48.76% in 2023, owing to the growing demand for genetically modified crops and organisms. Furthermore, the transfection & gene editing segment is expected to grow at the fastest CAGR over the forecast period.
• Based on end use, the academic & research institutes segment led the market with the largest revenue share of 40.12% in 2023, driven by their significant contribution to R&D to bring novel gene therapy treatments and engineered biotechnological products to market. Also, the contract research organizations segment is expected to expand at the fastest CAGR of 13.38% during the forecast period, due to their increasing adoption and investment in advanced research and manufacturing technologies
• North America dominated the market with the largest revenue share of 40.58% in 2023, owing to factors such as increasing investments in R&D activities, rising demand for personalized medicine, and advanced biotechnology research infrastructure

Plasmid Purification Market Segmentation

Grand View Research has segmented the global plasmid purification market based on product & service, grade, application, end-use, and region:

Plasmid Purification Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

• Products
• Instruments
• Kits & Reagents
• Services

Plasmid Purification Grade Outlook (Revenue, USD Million, 2018 - 2030)

• Molecular Grade
• Transfection Grade

Plasmid Purification Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cloning & Protein Expression
• Transfection & Gene Editing
• Others

Plasmid Purification End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Plasmid Purification Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Australia Nicotine Replacement Therapy Market To Reach $226.74 Million By 2030

 The Australia Nicotine Replacement Therapy Market size is projected to reach USD 226.74 million by 2030, and is anticipated to register a CAGR of 4.10% from 2024 to 2030, according to a new study by Grand View Research, Inc. Increasing emphasis on smoking cessation programs coupled with growing awareness about the ill effects of tobacco consumption are expected to fuel the market growth during the forecast period.

Smoking cessation laws and campaigns are also playing a crucial role in increasing awareness about diseases caused due to smoking. For instance, in September 2023, the Australian Government introduced tobacco control legislation in the parliament to fight against nicotine and tobacco addiction. In addition, global organizations such as the World Health Organization are also working toward creating awareness by running online campaigns. Public health campaigns employ powerful imagery and real-life stories to vividly convey the health risks associated with smoking. Healthcare professionals play a pivotal role by discussing the links between smoking and severe illnesses with patients. Schools integrate anti-smoking messages into their curricula, emphasizing the impact of smoking on health, social life, and future prospects.

Furthermore, according to a study published by the Australian Institute of Health and Welfare in 2023, people aged 40 years and above are likely to smoke 20+ cigarettes per day in the country. However, after understanding its negative impact on health, people are opting for cessation therapies. For instance, according to a study published by the government of Australia in 2023, the volume of cigarettes consumed in 2023 was much less than in 2017. Australia increasingly emphasized smoking cessation as a significant public health priority. The country recognizes the profound impact of tobacco use on individual health & the broader healthcare system. As part of its commitment to reducing smoking rates, Australia has implemented a multifaceted approach.

However, a stringent regulatory framework for the sale and marketing of NRT products is expected to act as a restraint to the market. The use of e-cigarettes is highly regulated and restricted for certain applications. For instance, the utilization of e-cigarettes containing nicotine requires a mandatory prescription. Australia's regulatory stance on nicotine-containing products has undergone changes and adjustments to achieve a balance for promoting harm reduction & addressing public health concerns. The regulations aim to provide clarity and accountability while also acknowledging the potential benefits of harm-reduction strategies for smokers.

List of Key Players in the Australia Nicotine Replacement Therapy Market

• Philip Morris Products S.A. (Altria Group)
• British American Tobacco p.l.c.
• Haleon Group of Companies
• Johnson & Johnson
• Liber Pharmaceuticals Pty Ltd
• Alphapharm Pty Limited
• Perrigo Company plc
• Amcal
• GSK plc

Request a free sample copy or view report summary: Australia Nicotine Replacement Therapy Market Report

Australia Nicotine Replacement Therapy Market Report Highlights

• Based on product, the nicotine replacement therapy segment held the largest revenue share in 2023 owing to the lucrative subsidies, product availability, and innovative products. Furthermore, industry developments such as distribution agreements are also projected to offer a favorable environment for segment growth
• Based on distribution channel, the offline segment dominated the market in 2023. Substantial emphasis of the people to get advice about nicotine replacement therapy products and buying convenience are estimated to drive offline segment growth during the forecast period
• The online distribution channel segment in the Australia NRT market is expected to witness considerable growth due to consumer preferences, user-friendly platforms, faster shipping, and optimum prices

Australia Nicotine Replacement Therapy Market Segmentation

Grand View Research has segmented the Australia nicotine replacement therapy market based on product and distribution channel:

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Nicotine Replacement Therapy
• Inhalers
• Gum
• Transdermal Patches
• Sublingual Tablets
• Lozenges
• Others
• E-Cigarettes
• Heat-not burn Tobacco Products

Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online
• Offline
• Hospital Pharmacies
• Retail Pharmacies
• Others

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Mortuary Equipment Market By Roftek Ltd.; SM Scientific Instruments Pvt. Ltd.; KUGEL Medical GmbH; Leec Limited

The global Mortuary Equipment Market size is expected to reach USD 1.55 billion in 2030 and is projected to grow at a CAGR of 5.6% from 2025 to 2030. Rising demand for automation in mortuary-related procedures, including autopsy, body embalming, shifting, and storage has resulted in technological advancements in these equipment. Growing usage of advanced devices is expected to drive the market during the forecast period.

Rising opportunities in private healthcare sector provide huge scope for increase in the number of hospitals, thus, increasing the number of morgues. In addition, the entry of private morgues, which also offer funeral services, is expected to play an important role in increasing the demand for these equipment during the forecast years. Introduction of technically advanced devices that reduce procedural timings and increase convenience of the professionals is anticipated to drive the market.

In addition, cultural factors, such as funeral traditions, have varying impacts on the market growth. In regions where Christianity is dominant, the demand for private morgue services is high. On the other hand, as per Hindu and Buddhist traditions the dead are cremated; hence, in regions where other religions are prevalent, the usage of morgue, is limited to hospitals.

List of Key Players in Mortuary Equipment Market

• Roftek Ltd.
• SM Scientific Instruments Pvt. Ltd.
• KUGEL Medical GmbH
• Leec Limited
• Thermo Fisher Scientific Inc.
• Mortech Manufacturing Company Inc.
• HYGECO
• Mortuary Lift Company
• Fiocchetti Scientific S.R.L.

Request a free sample copy or view report summary: Mortuary Equipment Market Report

Mortuary Equipment Market Report Highlights

• The study suggests that refrigeration units dominated the market with a revenue share of 30.3% in 2024. High demand for the customized storage units and usage of different size refrigeration units for optimizing space are driving growth
• Huge focus on developing innovative technologies in autopsy devices, including platform and other accessories, used in the procedure
• Shifting preference of funeral procedures from burial to cremation in order to save costs is expected to hamper the growth rate of embalming workstation segmen
• North America dominated this industry in 2024, with the U.S. capturing the largest share
• Higher demand for private morgues and faster adoption of advanced technologies are the factors driving growth in this region
• Asia pacific is expected to exhibit the fastest growth during the forecast period. Growing number of hospitals and emergence of local players are the factors expected to fuel the growth.

Related Press Release@ Mortuary Equipment Industry Analysis

Mortuary Equipment Market Segmentation

Grand View Research has segmented the global mortuary equipment market report based on type and region

Mortuary Equipment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Trolleys
• Refrigeration Units
• Autopsy Platforms And Equipment
• Embalming Workstation
• Dissection Table
• Other Accessories

Mortuary Equipment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

U.S. Single-use Bioprocessing Market Size To Reach $21.41 Billion By 2030

 The U.S. Single-Use Bioprocessing Market size was estimated at USD 9.34 billion in 2024 and is projected to grow at a CAGR of 15.04% from 2025 to 2030. Due to the high demand for biopharmaceuticals, suppliers have made their disposable product offerings more robust and inclusive. Single-use equipment suppliers are trying to fulfill end users' growing and ever-changing expectations.

The U.S. single-use bioprocessing industry experienced a positive impact from the COVID-19 pandemic, particularly due to the increased demand for single-use products driven by the heightened need for vaccines, treatments, and assays. These products played an important role in facilitating the rapid scaling up of production by biopharmaceutical companies to meet the unprecedented global demand for vaccines. The pandemic underscored the importance of maintaining sterility and minimizing contamination risks in pharmaceutical and biologics production, highlighting the significance of single-use products in such scenarios.

Key U.S. Single-use Bioprocessing Companies:

• Sartorius AG
• Danaher
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Avantor, Inc.
• Eppendorf SE
• Corning Incorporated
• Meissner Filtration Products, Inc.
• Lonza
• PBS Biotech, Inc.

Request a free sample copy or view report summary: U.S. Single-use Bioprocessing Market

U.S. Single-use Bioprocessing Market Report Highlights

• The simple & peripheral elements segment held the largest market share of 48.54% in 2024 due to continuous innovations in these products and the increasing prominence of bioprocessing operations in manufacturing.
• The upstream segment dominated the U.S. market with a share of 57.80% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
• In 2023, biopharmaceutical manufacturers held the largest market share in the end use segment and are anticipated to grow at the fastest CAGR over the forecast period.

Recent Development

• In August 2024, Freudenberg Medical expanded its biopharma portfolio with custom single-use assemblies, including Y-connector manifolds, tubing, and bottle cap assemblies, for critical fluid transfer in labs and CGMP bioprocesses.
• In July 2024, Qosina partnered with Polestar Technologies, experts in monitoring O2, CO2, and pH, and added Polestar's iDOT Single-Use Sensor Bag Ports to its product portfolio.
• In June 2023, Sartorius AG partnered with Waters Corporation to create integrated analytical solutions for downstream biomanufacturing, expanding their existing agreement.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Tissue Diagnostics Market By F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Thermo Fisher Scientific, Inc.; Siemens

 The global Tissue Diagnostics Market size is expected to reach USD 14.03 billion by 2030, registering a CAGR of 8.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to a lack of skilled pathologists has driven the tissue diagnostics industry. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplements the market growth.

The use of digital slides has significantly increased in recent years, owing to its associated benefits including flexible magnification and remote access to slides. The growing emphasis on precision medicine is supported by several organizations & companies in the U.S., which is expected to contribute to the market growth. Additionally, companies are supporting the development of precision medicine with novel oncology solutions. For instance, in May 2020, QIAGEN launched new oncology solutions, such as the QCI Interpret One software solution for genomic profiling of tumors. The advancements in imaging techniques are expected to positively influence market growth.

In addition, one of the emerging trends in the tissue diagnostics industry is the integration of digital pathology and artificial intelligence (AI). Digital pathology involves the scanning and digitization of tissue slides, allowing pathologists to review and analyze images remotely. AI algorithms can then be applied to these digital images to aid in the interpretation and analysis of tissue samples. This integration enables faster and more accurate diagnoses, enhances workflow efficiency, and improves patient care. It also facilitates the development of predictive models and precision medicine approaches. As a result, there is a growing demand for digital pathology solutions and AI-driven tissue diagnostics platforms in the market.

With technological improvements in imaging techniques, the sensitivity of detection and diagnosis of breast cancer has also improved. For instance, in May 2023, with an emphasis on AI-guided breast cancer diagnoses, BPGbio recently announced an agreement with the Department of Defense (DoD). The new panel, created with artificial intelligence, is intended to detect women diagnosed with ER+ breast cancer but do not react to hormone therapy, allowing for more suitable treatment alternatives and improving treatment response.

The unique 34-gene breast cancer diagnostic panel from BPGbio will also receive wider evaluation through the Interrogative Biology Platform, focusing on ER+ breast cancers, which are significantly rising. Technological expansion in breast tissue analysis includes procedures for evaluating gene expression, cellular biochemistry, and molecular biology using digital methods, tomosynthesis, CAD, and other methods.

List of Key Players in the Tissue Diagnostics Market

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Siemens
• Danaher
• bioMérieux SA
• QIAGEN
• BD
• Merck KGaA
• GE Healthcare
• BioGenex
• Cell Signaling Technology, Inc.
• Bio SB
• DiaGenic ASA
• Agilent Technologies

 

Request a free sample copy or view report summary: Tissue Diagnostics Market Report

Tissue Diagnostics Market Report Highlights

• The immunohistochemistry segment dominated the market in terms of revenue share of 25.79% in 2024. Immunohistochemistry (IHC) is a special staining test in which a diagnostic antibody is bound to a specific target protein present in cell membranes or cells on slides containing tissue samples.
• The digital pathology and workflow segment is anticipated to grow at the fastest CAGR of 12.22%. Digital pathology and workflow integration have revolutionized the application of ISH by enhancing imaging, data management, and analysis.
• The breast cancer segment held the largest market share of 50.45% in 2024 and is anticipated to grow at the fastest CAGR. The increasing incidence of breast cancer due to lifestyle changes and rapidly aging global population provide lucrative growth opportunities for the segment.
• The clinical market segment dominated the market in 2024 and is anticipated to grow at the fastest CAGR of 8.83% over the forecast period, driven by advancements in medical technology, increasing disease prevalence, and a rising demand for precise & personalized medicine.
• The hospitals dominated the market with the largest revenue share of 37.82% in 2024. The usage of tissue diagnostic systems and services in hospitals & clinics has increased over the years. In several hospitals and clinics, physicians are switching to tissue diagnostic tests from conventional testing procedures.
• North America tissue diagnostics market accounted for a 44.76% share in 2024, driven by a rising demand for advanced diagnostic tools due to the increasing prevalence of cancer and other diseases.

Related Press Release@ Tissue Diagnostics Industry Analysis

Tissue Diagnostics Market Segmentation

Grand View Research has segmented the global tissue diagnostics market on the basis of on technology, modality, application, end-use, and region:

Tissue Diagnostics Technology Outlook (Revenue, USD Million; 2018 - 2030)

• Immunohistochemistry
• Instruments

• Slide Staining Systems
• Tissue Microarrays
• Tissue Processing Systems
• Slide Scanners
• Cell Processors
• Microtomes
• Embedding Systems
• Cover Slippers
• Other Products
• Consumables
• H&E Stainer Coverslipper
• IHC Stainer Coverslipper
• Antibodies
• Others IHC reagents
• In Situ Hybridization
• Instruments
• Stainers
• Others
• Total
• Consumables
• Software
• Primary & Special Staining
• Digital Pathology And Workflow
• Image Analysis Informatics
• Information Management System Storage & Communication
• Anatomic Pathology
• Instruments
• Microtomes & Cryostat Microtomes
• Tissue Processors
• Automatic Strainers
• Other Products
• Consumables
• Reagents & Antibodies
• Probes & Kits
• Others
• Molecular Pathology
• Instruments
• Reagents
• Fluorescence Reagents
• Others
• Others

Tissue Diagnostics Application Outlook (Revenue, USD Million; 2018 - 2030)

• Breast Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer
• Gastric Cancer
• Other Cancers

Tissue Diagnostics Modality Outlook (Revenue, USD Million; 2018 - 2030)

• Clinical
• Pharma / CRO / Research Market

Tissue Diagnostics End-use Outlook (Revenue, USD Million; 2018 - 2030)

• Hospitals
• Diagnostic Center
• Pharmaceutical Organizations
• Contract Research Organizations (CROs)

Tissue Diagnostics Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• Spain
• France
• Italy
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com